Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden.
about
The Role of PARP Inhibitors in the Treatment of Gynecologic MalignanciesFamilial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases.STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1BRCAness: finding the Achilles heel in ovarian cancerTP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague areaFine tuning chemotherapy to match BRCA1 statusPathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.Role of BRCA2 mutation status on overall survival among breast cancer patients from SardiniaThe BARD1 Cys557Ser variant and breast cancer risk in IcelandProspective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol.The relationship between prognostic and predictive factors in the management of breast cancer.Forth nightly review: hereditary ovarian carcinoma.The role of BRCA status on the prognosis of patients with epithelial ovarian cancer: a systematic review of the literature with a meta-analysis.Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer PatientsProphylactic mastectomy and inherited predisposition to breast carcinoma.Clinical management of BRCA1- and BRCA2-associated breast cancer.Rates of BRCA1/2 mutation testing among young survivors of breast cancerOvarian cancer: epidemiology, biology, and prognostic factors.Management of familial breast cancer risk.The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancerDiffering clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer.Host susceptibility to cancer progression.Clinical management of women with genomic BRCA1 and BRCA2 mutations.A genomic instability score in discriminating nonequivalent outcomes of BRCA1/2 mutations and in predicting outcomes of ovarian cancer treated with platinum-based chemotherapyHereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.Hereditary breast cancer and handling of patients at risk.Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.Family history of breast cancer in relation to tumor characteristics and mortality in a population-based study of young women with invasive breast cancerImproved survival in BRCA2 carriers with ovarian cancerImproved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival.Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients.Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival.Comparison of whole genome amplification and nested-PCR methods for preimplantation genetic diagnosis for BRCA1 gene mutation on unfertilized oocytes-a pilot study.Survival in Norwegian BRCA1 mutation carriers with breast cancer.Molecular genetics analysis of hereditary breast and ovarian cancer patients in India.Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.
P2860
Q21129302-7D80B53A-B8E6-4358-A939-843BE82B2F4BQ21260436-00FBEA5C-0427-497D-8A49-165CD1CDD611Q24600363-6CDA2C57-A9DB-488B-8B69-F04CB602B2C9Q24630872-AC14701F-0CA3-4187-80E3-CE8F840E1939Q24812743-DD6E4B27-870F-492E-A0E5-A4ECC2ED5B63Q24813558-B6A3A58B-7CE0-4159-9B65-A12D2A9B4532Q27694529-CF58EF0D-C306-4DBE-8D34-E760CCE025EFQ30370475-1030D3E0-2CC8-4FFE-B91D-99B1C714F403Q30858718-7F49AEFA-86C0-48B1-A033-E4E6AAF58B76Q33246499-C7013AEF-0BAF-48EA-B0D8-E4DCE9F9BBA4Q33294128-660F3549-A8C4-436B-B0CB-70BE4068BEC7Q33538455-397B0ECC-AFF0-4D17-B69B-B932134ADA42Q33542652-0EEDC15A-948C-4339-9D23-1325C9F0A3A4Q33553318-E5340756-9FDB-4392-8939-4BC8B27C18AFQ33584055-EA2646CE-D5CD-4E6B-AF96-6F3066739936Q33813985-1D54F790-B9EE-40C3-A56D-4C0D6880C397Q33915589-46864D18-064F-42B8-9292-8E3E1FE1D938Q33923031-79378EA2-5E3A-41D3-AE13-C7C6E401719BQ33959805-BB284A01-1A44-4485-90A2-85AE4D451438Q34034858-391E91E1-8044-433D-A4DD-1EF054111EE2Q34146408-E2EC6068-4C23-4A6A-91E0-938E711DEAA8Q34155131-4F82A525-750F-40EC-8C88-1399DFD3B0B3Q34305493-C2D882A2-8CE0-4A5D-8290-056BB6E4EA8FQ34386296-6EA508D3-A406-4B2B-B2F1-E6C761C19809Q34472527-EB1597AF-B797-4970-9751-E9E0B1BBE1A3Q34599539-3A2CE0B8-E40C-4969-9749-EFA0EFF8F7A7Q34977063-656071CA-4C20-4659-A717-087F4093BA29Q35008189-FF4ADD16-4DB9-4287-89FA-7F7D5D538672Q35039478-3D0AF126-5737-4297-B0BB-AF82D6A0BDA4Q35224593-338E2EEB-6940-4355-B9F7-3C1A9984D8D8Q35623408-E46F20CC-81C8-44DE-87D3-6BFA53AFE930Q35828679-916CCBAA-10DB-4B94-9E1A-17E1C01D29DEQ35848153-2BB91E96-18D6-4ED2-8B68-A76B1941AC0BQ35914568-15ED71F8-04B3-4BF8-8DE4-67EA22BA6776Q36446316-94C956D8-39CA-4CE2-AE95-056ADDD5B99BQ36983535-FC3190CF-4846-4D8D-ABFE-820AA1B26576Q37116781-ACBC8F5B-39E9-48D9-810B-393F97CD6B76Q37182133-C9EC56E0-88D4-4CD7-B6A5-BEE138392648Q37316299-B04BAD65-B61C-4D12-BDDD-4B4DA04BEED7Q37585309-C843A3A7-1C0E-4282-AF33-A6E8E60D2027
P2860
Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Survival of BRCA1 breast and o ...... ed study from southern Sweden.
@en
type
label
Survival of BRCA1 breast and o ...... ed study from southern Sweden.
@en
prefLabel
Survival of BRCA1 breast and o ...... ed study from southern Sweden.
@en
P1476
Survival of BRCA1 breast and o ...... ed study from southern Sweden.
@en
P2093
O T Jóhannsson
P304
P356
10.1200/JCO.1998.16.2.397
P407
P577
1998-02-01T00:00:00Z